Stockreport

BioMarin Pharmaceutical (BMRN) Receives FDA Approval for Expanded Use of PALYNZIQ in Adolescents [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF On February 27, the US FDA approved BioMarin's supplemental Biologics License Application for PALYNZIQ, expanding its use to include adolescents aged 12 and older with p [Read more]